Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Maculopapular Cutaneous Mastocytosis

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Maculopapular Cutaneous Mastocytosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chesterman, CN; Earl, JW; Kemp, A; Krilis, SA; Macpherson, JL; Mallet, AI; Rogers, M; Spur, B; Toia, RF1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Maculopapular Cutaneous Mastocytosis

ArticleYear
Occurrence of platelet-activating factor (PAF) and an endogenous inhibitor of platelet aggregation in diffuse cutaneous mastocytosis.
    Clinical and experimental immunology, 1989, Volume: 77, Issue:3

    Topics: Blister; Humans; Infant, Newborn; Male; Platelet Activating Factor; Platelet Aggregation Inhibitors; Urticaria Pigmentosa

1989